Baltimore-Washington Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Baltimore-Washington Financial Advisors's LLY Position: Q2 2026 in Review
Baltimore-Washington Financial Advisors increased its Eli Lilly (LLY) stake by 14% in Q2 2026, buying an estimated $375K and bringing the position to 2,906 shares worth $3.49M. The position accounts for 0.13% of the portfolio, ranked #76.
Baltimore-Washington Financial Advisors first reported a position in LLY in Q4 2014 and has held it in 15 quarters since. The position peaked at $3.63M in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Baltimore-Washington Financial Advisors held 2,906 shares of Eli Lilly worth $3.49M as of Q2 2026.
- Baltimore-Washington Financial Advisors bought 367 Eli Lilly shares in Q2 2026, an estimated $375K.
- Eli Lilly made up 0.13% of Baltimore-Washington Financial Advisors's portfolio in Q2 2026, its #76 holding.
- Baltimore-Washington Financial Advisors first reported a position in Eli Lilly in Q4 2014 and has held it in 15 quarters since.
- Baltimore-Washington Financial Advisors's Eli Lilly position peaked at $3.63M in Q4 2025.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Baltimore-Washington Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.